secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIMEDX GROUP, INC. (MDXG)
CIK:        0001376339
Form:       8-K
Filed at:   2026-07-29T20:03:54+00:00
Accession:  0001376339-26-000070
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiMedx to acquire Sanara MedTech for $35/share in cash and stock, ~$350M enterprise value
--------------------------------------------------------------------------------

- MiMedx to acquire Sanara MedTech for $35 per share ($33 cash + 0.4735 MDXG shares), total enterprise value ~$350M.
- Transaction expected to be immediately accretive to revenue growth, gross margin, and adjusted EBITDA margin; over $20M in run-rate cost synergies.
- MiMedx secured $300M debt commitment from Hayfin Capital Management to finance cash consideration and refinance existing debt.
- Sanara stockholders holding ~38.9% of voting power have agreed to vote in favor via voting agreement.
- Closing expected late 2026/early 2027, subject to Sanara stockholder approval, HSR clearance, and other conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1376339/000137633926000070/0001376339-26-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1376339/000137633926000070/mdxg-20260729.htm
  HTML page:      https://secwatch.observer/filing/0001376339-26-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer